Overview

Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis

Status:
Withdrawn
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
We propose to study the effects of Xolair on patients with chronic sinusitis with or without nasal polyps. Because of the similarities between the inflammatory processes found in asthmas and rhinitis to those found in chronic sinusitis, we hypothesize that sinusitis should respond to Xolair, just as asthma.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
University of Chicago
Treatments:
Antibodies
Omalizumab